Company Filing History:
Years Active: 1997
Title: **Inventor Spotlight: David P. Greenen**
Introduction
David P. Greenen is an accomplished inventor based in Indianapolis, IN, who has made significant contributions to the field of biotechnology. With a keen focus on genetic innovations, Greenen has been pivotal in developing technologies that advance our understanding of enzymes and their applications.
Latest Patents
David P. Greenen holds one patent, which is titled "DNA sequences encoding porcine pancreatic carboxypeptidase B." This invention involves the DNA encoding porcine Pro-carboxypeptidase B, alongside vectors comprised of this DNA and host cells that have been transformed with the vectors. His work is instrumental in the production of porcine carboxypeptidase B, which has various applications in the medical and pharmaceutical industries.
Career Highlights
Throughout his career, Greenen has made notable strides while working at Eli Lilly and Company, a leader in the pharmaceutical sector. His work there exemplifies a commitment to innovation and the development of crucial biotechnological processes that can enhance drug production.
Collaborations
David has collaborated with distinguished colleagues, including Jeffrey T. Fayerman and Charles L. Hershberger. These partnerships have facilitated a productive exchange of ideas, strengthening the development of innovative solutions in biotechnology.
Conclusion
David P. Greenen represents the spirit of innovation within the biotechnology sector. His patent highlights the potential of genetic technologies in transforming healthcare solutions, making him a notable figure in the realm of inventions related to enzyme production. As research continues to evolve, the contributions of inventors like Greenen will undoubtedly pave the way for future advancements in the industry.